VTRS - Viatris Inc
IEX Last Trade
12.455
0.005 0.040%
Share volume: 102,849
Last Updated: Fri 27 Dec 2024 08:30:27 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$12.45
0.01
0.04%
Fundamental analysis
23%
Profitability
6%
Dept financing
43%
Liquidity
55%
Performance
27%
Performance
5 Days
0.56%
1 Month
-4.99%
3 Months
8.74%
6 Months
19.85%
1 Year
16.62%
2 Year
13.77%
Key data
Stock price
$12.46
DAY RANGE
$12.40 - $12.66
52 WEEK RANGE
$10.18 - $13.62
52 WEEK CHANGE
$15.97
DIVIDEND
$0.12
EX-DIVIDEND DATE
08/23/2024
NEXT EARNINGS DATE
11/05/2024
Company detail
CEO: Michael Goettler
Region: US
Website: viatris.com
Employees: 37,000
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: viatris.com
Employees: 37,000
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Viatris Inc. operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies.
Recent news